5-Benzoyl-1,3,6-trimethyl-2,4(1H,3H)-pyrimidinedione, 97%, 1g

9-Hexyl-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole>98.0%(HPLC)(N)5g

5-Fluoro-1H-imidazole, 95.0%, 100mg

2-Methoxypyrimidine-5-carbonitrile, 97%, 5g

2-(2-Fluoro-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

1-Eth-1-ynyl-4-propylbenzene, 97.0%, 25g

2,6-Dibromopyridine-3-carboxylic acid, 98.0%, 100g

p-(ethoxymethyl)anisole, 95%, 250mg

Ethyl 3-chloropyridazine-4-carboxylate, 95.0%, 5g

4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 96%, 1g

MORACIN M, 95%, 250mg

Pipetta microlitro monocanale mLINE® variabile, da 500 a 5000 µl, 1 pezzo

N-(3-Bromopropyl)phthalimide, 98.0%, 100g